Akash Patnaik, MD, PhD, MMSc
@AkashPatnaik7
Followers
395
Following
187
Media
2
Statuses
202
Medical Oncologist/Physician-Scientist passionate about translational research, cancer medicine and international travel.
University of Chicago
Joined October 2016
Thrilled to share our recent team science article unraveling TAM heterogeneity across PC disease spectrum & therapeutic targeting of "bad actor" SPP1+/TREM2+ TAM subsets in mCRPC: @PCF_Science @UChicagoHemOnc @UCCancerCenter @UChicagoCCB @TheVFoundation.
0
5
15
It was an honor to celebrate with friends, colleagues, mentors and family @the_asci induction ceremony, without whom this would not have been possible! @UChicagoHemOnc @UCCancerCenter @UChicagoMed @UChicagoCCB.
Congratulations to Dr. @AkashPatnaik7 who was recently elected to the American Society for Clinical Investigation!! This is a prestigious honor for physician-scientists who are making a significant impact in their field—something Dr. Patnaik does every day!.@UCCancerCenter
2
0
10
It was an inspiring day with great discussions! Thanks to everyone who contributed to making this a memorable retreat! @UChicagoHemOnc @UCCancerCenter.
#FBF to our Hem/Onc Translational Research Retreat last week! A day spent brainstorming transformative, interdisciplinary team science ideas/opps across campus, academic-industry partnerships, & recruitment! w/ @ChicagoITM @UChiPritzker & Ctr for Chemical Biology & Therapeutics
0
0
8
RT @TylerSbrt: Please save the @DeptofDefense Prostate Cancer Research Program! We need continued funding to keep fighting #ProstateCancer….
0
34
0
RT @SashaGusevPosts: Not only has the NIH supported the most important drugs and treatments to date, the modern era of genomically driven d….
0
126
0
I receive my election to @ASCI with utmost humility & profound gratitude. Heartfelt thanks to my research team, mentors, mentees, patients & family without whom this would not be possible.@UCCancerCenter @UChicagoHemOnc @PCF_Science @TheVFoundation @theNCI
linkedin.com
University of Chicago physician-scientist Akash Patnaik, MD, PhD, MMSc, has been elected to the The American Society for Clinical Investigation (ASCI), one of the oldest and most esteemed nonprofit...
Congratulations to Dr. Akash Patnaik for his election into the American Society for Clinical Investigation. He stands out as a physician-scientist who has made outstanding contributions to the understanding of advanced prostate cancer. @the_asci @AkashPatnaik7
11
1
39
Thank you @MassimoLodaMD @WCMCPathology! An honor to present our work and reconnect with superstar colleagues, friends and trainees at @WeillCornell and @MSKCancerCenter!.@UChicago @UChicagoMed @UCCancerCenter @UCHemOncFellows @UChicagoCCB @UChicagoHemOnc @PCF_Science
We hope you can join us today for our next @WCMCPathology #GrandRounds, presented by Dr. Akash Patnaik (@AkashPatnaik7), Assoc. Prof. of Medicine @UChicagoMed Comprehensive Cancer Ctr. Today at noon, room C-405. Come for the science (🧪🧪), stay for the pizza (🍕🍕)!.
1
3
34
Honored to present our translational research at @TheVFoundation symposium. Thank you for the invtation and your support! @UCCancerCenter @UChicagoMed @UChicagoHemOnc @UofC @UChicagoCCB.
It’s personal for our researchers. @AkashPatnaik7 from @UChicagoMed shares how he lost his uncle to prostate cancer and how that gave him the drive to research this type of cancer.
1
3
24
Thanks @urotoday and @AndreaMiyahira for the opportunity to discuss our work and to @PCFnews for funding support! @PCFScience @UCCancerCenter @UChicagoMed @UChicagoCCB @UChicagoHemOnc.
Strategically targeting lactate in #ProstateCancer: Clinical insights into tumor control and the development of next-generation therapeutics. @AkashPatnaik7 @UChicago joins @AndreaMiyahira @PCFnews to discuss his team's research on UroToday >
0
1
15
An honor to have a Great Debate with my esteemed friend @gulleyj1 from @NCI on combination therapies vs. bispecific/tri-specific antibody approaches to @endcancer at #Bridge2023 meeting in Naples! @UCCancerCenter @UChicagoHemOnc @UChicagoMed @UChicagoCCB @UChicagoMed @sitccancer
0
1
24
Great to reconnect with friends & present our work at the best Immunotherapy #Bridge23 meeting in Naples. Thanks @PAscierto for organizing a fantastic meeting to @endcancer ! @UCCancerCenter @UChicagoHemOnc @UChicagoCCB @UChicago @UChicagoMed @PCF_Science @PCFnews @SITCCancer.
#Bridge23 | @AkashPatnaik7 from beside to bench in prostate cancer: IO combination therapies will have a role in the future treatment algorithm. #crpc @UChicagoMed @PAscierto
0
1
14
Thrilled to share our story demonstrating NLRP3 infammasome as an androgen receptor (AR)-regulated phagocytic checkpoint within tumor-associated macrophages (TAM), which drives TAM-mediated tumor clearance upon priming with AR blockade and NLRP3 agonism:
biorxiv.org
Immune-based therapies induce durable remissions in subsets of patients across multiple malignancies. However, there is limited efficacy of immunotherapy in metastatic castrate-resistant prostate...
0
13
36
Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete/durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! @KiranjChaudagar @CCR_AACR @PCFnews .@PCF_Science@UChicagoHemOnc
0
4
14
Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete and durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! @CCR_AACR @PCFnews @PCF_Science @UChicagoHemOnc @UChicagoMed .
1
8
41
We are hiring for open Lab Manager and postdoctoral research fellowship positions! If you are passionate about tumor immunology, novel immunotherapeutics and/or prostate cancer translational research, please reach out or circulate. Thanks!.
0
8
23
RT @UCHemOncFellows: And finally but most importantly a very warm welcome to our fantastic new first year fellows!! We’re so excited to hav….
0
2
0
Lovely to see old friends and colleagues & present our work on innate immune activation in prostate cancer at my favorite Coffey-Holden #PCFAcademy brainstorm meeting! Thanks to @PCF_Science and organizing committee for a fantastic meeting that will move the field forward!.
Thank you to all who attended & presented at the 2023 @PCFnews Coffey-Holden #PCFAcademy & made this such an incredible conference! .A special thanks to our Committee: @sophia_kamran Tamara Jamaspishvili, @TylerSbrt @CathyHandy @KMaxwellLab @abhijitparolia & Nicholas Zorko!
1
2
11
Congrats to the TRITON2 team on yet another recent publication reporting the final results of the Phase 2 study which led to the FDA approval of rucaparib in mCRPC! We learned a lot, and it has been an honor to be part of this effort! @clovisoncology .
1
2
5
RT @RPachynski: Amazing teams- both @Cardinals and @PCFnews @PCF_Science 🎉 …please donate to help save lives from #prostatecancer 🙏🏼 @soule….
0
2
0